Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — FY2018 Earnings Presentation
18 slides from Trendlines's earnings presentation, Feb 20, 2019
Slide 1: The Trendlines Group Financial Highlights FY2018
The Trendlines Group Financial Highlights FY2018 Steve Rhodes Todd Dollinger Haim Brosh Chairman and CEO Chairman and CEO Chief Financial Officer 20 February 2019 SGX:42T OTCQX: TRNLY
Slide 2: Agenda
Agenda • Corporate highlights • Financial highlights • Post FY 2018 developments 2
Slide 3: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 4: Corporate highlights
Corporate highlights
Slide 5: 11 years of portfolio value expansion
11 years of portfolio value expansion Note: For 2018, the portfolio value does not reflect all current portfolio companies due to consolidation of 5 newly-formed US$ millions Portfolio value with exit proceeds companies as subsidiaries controlled by The Trendlines Group. 140 120 Portfolio value* (ex
Slide 6: Key financial developments FY 2018
Key financial developments FY 2018 31 December 2018 31 December 2017 Change % Change Portfolio value US$ 97.2 million US$ 96.8 million US$ 0.4 million N.M.* Book value US$ 86.4 million US$ 92.9 million - US$ 6.5 million -7.0% Current assets US$ 11.8 million US$ 20.4 million - US$ 8.6 million -42.2%
Slide 7: Key corporate developments FY 2018
Key corporate developments FY 2018 • B. Braun Medical SAS, announced as acquirer of Stimatix GI Ltd.’s assets • MOU signed with Nutreco NuFrontiers and Sirius VC (Brazil) • Trendlines Medical Singapore and A*ccelerate signed MOU • Established 10 new portfolio companies • 20 portfolio companies compl
Slide 8: 10 companies to watch
10 companies to watch* • ApiFix Ltd. • Leviticus Cardio Ltd. • Arcuro Medical Ltd. • OrthoSpin Ltd. • BioFishency Ltd. • Saturas Ltd. • Fidmi Medical Ltd. • STS Medical Ltd. • Gordian Surgical Ltd. • ViAqua Therapeutics Ltd. *Updated report issued 23 January 2019 8
Slide 9: A game changer in heart pump technology
A game changer in heart pump technology 9
Slide 10: Highlights from the "10 Companies to Watch" report
Highlights from the “10 Companies to Watch” report • ApiFix Ltd. and Gordian Surgical Ltd. completed >275 surgeries and >500 surgeries respectively • Arcuro Medical Ltd. completed 9 successful first-in-human meniscus repair procedures • STS Medical Ltd. preparing manufacturing capabilities for first
Slide 11: Financial highlights
Financial highlights
Slide 12: Consolidated income statement
Consolidated income statement Group Full Year Ended 31 December 2018 31 December 2017 (Unaudited) (Audited) Change US$’000 US$’000 % Income: Gain (loss) from change in fair value of investments in Portfolio Companies (6,046) 9,399 N.M Income from services to Portfolio Companies 5,760 4,904 17.46 Gro
Slide 13: Key value components
Key value components Change in portfolio value during FY2018 Balance sheet as at 31 December 2018 (US$ millions) 14 (13.6) 11.8 (3) (5) (13.7) (0.9) 96.8 97.2 86.4 Net portfolio Investments Fair value Net portfolio Cash, short- Fair value of Deferred Deferred tax** Payables & Total equity value 31.1
Slide 14: Post FY 2018 developments
Post FY 2018 developments
Slide 15: Post FY 2018 developments
Post FY 2018 developments • Two medical portfolio companies established in Singapore as a result of collaboration agreement between Trendlines Medical Singapore Pte. Ltd., National Healthcare Group, and A*ccelerate • Management changes for 2019 announced • Publicized successful first in human case f
Slide 16: Looking ahead: Trendlines Agrifood Fund
Looking ahead: Trendlines Agrifood Fund US$40 million agrifood tech-focused venture fund • Will employ a blended early/late-stage investment strategy to • achieve early exits • attain IRR of at least 20% Singapore Government Support Trendlines Group VP Nitza Kardish, PhD, • Prominent Singapore inves
Slide 17: SGX: 42T OTCQX: TRNLY www.trendlines.com
SGX: 42T Steve Rhodes, Chairman & CEO OTCQX: TRNLY steve@trendlines.com Todd Dollinger, Chairman & CEO +972.72.260.7000 todd@trendlines.com www.trendlines.com Haim Brosh, Chief Financial Officer haim@trendlines.com 20 February 2019
Slide 18: Financial Statements and Related Announcement: Full Yearly Results
FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS Issuer & Securities Issuer/ Manager THE TRENDLINES GROUP LTD. Securities THE TRENDLINES GROUP LTD. - 1L0011328858 - 42T Stapled Security No Announcement Details Announcement Title Financial Statements and Related Announcement Date &T